Boehringer Ingelheim stops work on inhaled cystic fibrosis gene therapy
Boehringer Ingelheim stops work on inhaled cystic fibrosis gene therapy
المحتوى غير متاح. يرجى الرجوع إلى المصدر الأصلي.
Boehringer Ingelheim stops work on inhaled cystic fibrosis gene therapy
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.